key: cord-0982298-conmlu4m
authors: Selvaraj, P.; Wagner, B. G.; Chao, D. L.; Jackson, M. L.; Breugelmans, J. G.; Jackson, N.; Chang, S. T.
title: Rural prioritization may increase the impact of COVID-19 vaccines in Sub-Saharan Africa due to ongoing internal migration: A modeling study
date: 2021-06-21
journal: nan
DOI: 10.1101/2021.06.18.21259164
sha: ea7410c1f59a29c162a6ab75d3d313d681f9c8e3
doc_id: 982298
cord_uid: conmlu4m

How COVID-19 vaccine is distributed within low- and middle-income countries has received little attention outside of equity or logistical concerns but may ultimately affect campaign impact in terms of infections, severe cases, or deaths averted. In this study we examined whether subnational (urban-rural) prioritization may affect the cumulative two-year impact on disease transmission and burden of a vaccination campaign using an agent-based model of COVID-19 in a representative Sub-Saharan Africa country setting. We simulated a range of vaccination strategies that differed by urban-rural prioritization, age group prioritization, timing of introduction, and final coverage level. Urban prioritization averted more infections in only a narrow set of scenarios, when internal migration rates were low and vaccination was started by day 30 of an outbreak. Rural prioritization was the optimal strategy for all other scenarios, e.g., with higher internal migration rates or later start dates, due to the presence of a large immunological naive rural population. Among other factors, timing of the vaccination campaign was important to determining maximum impact, and delays as short as 30 days prevented larger campaigns from having the same impact as smaller campaigns that began earlier. The optimal age group for prioritization depended on choice of metric, as prioritizing older adults consistently averted more deaths across all of the scenarios. While guidelines exist for these latter factors, urban-rural allocation is an orthogonal factor that we predict to affect impact and warrants consideration as countries plan the scale-up of their vaccination campaigns.

Introduction 1 COVID-19 has presented every country with a challenge to formulate 2 a strategy to protect its population, initially with non-pharmaceutical in- CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.18.21259164 doi: medRxiv preprint table access. In particular the guidance encourages countries to give special 23 consideration to "those living in informal settlements or urban slums... pop- 24 ulations in conflict settings or those affected by humanitarian emergencies, 25 and other hard-to-reach population groups" but does not explore the epi-26 demiological impact of such policy decisions [7] . Likewise, WHO guidance 27 on logistics mentions "remote areas" but only with respect to the ultra-low 28 temperatures required to store certain vaccines and the need for special de- 29 vices such as thermal shippers with dry ice [9] . These documents highlight 30 the challenges that rural areas (and some urban areas) are expected to face 31 during COVID-19 vaccination campaigns and suggest that the default may 32 be to overlook these areas or distribute vaccine to these areas at a slower 33 pace. 34 In this study we ask whether urban or rural prioritization of COVID-19 35 vaccines may also affect the impact of the vaccination campaign on disease 36 burden. Using an agent-based model set in a representative Sub-Saharan 37 African (SSA) setting, we examine the possible impact on transmission and 38 3 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.18.21259164 doi: medRxiv preprint disease burden of campaigns prioritizing urban or rural areas to receive vac-39 cine first, while also accounting for other factors such as age group prior- CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.18.21259164 doi: medRxiv preprint Using the baseline scenario as reference, we examined the effects of trans-64 mission and migration separately on the epidemic characteristics ( Figure 1) .

CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Increasing the transmission rate (from R 0 = 2.0 to 2.8) while holding mi-66 gration constant shortened the time between urban and rural peaks (e.g., 67 6 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.18.21259164 doi: medRxiv preprint from 287 to 92 days when migration = 20 000 dtpmi, Figure 1 ). This also 68 resulted in a proportional increase in cumulative incidence as expected ( CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.18.21259164 doi: medRxiv preprint 2.0 and migration = 2000 dtpmi); cumulative incidence was 62% and 5% in 93 urban and rural areas, respectively, and 22% ± 2% at the country level (Fig-94 ure 2). A less contained, widespread outbreak was generated when transmis-95 sion and migration rates were high (R 0 = 2.8 and migration = 200 000 dtpmi); 96 cumulative incidence was 78% and 63% in urban and rural areas, respectively, 97 and 68% ± 2% at the country level ( Figure 2 ). This range of cumulative in-98 cidence was consistent with seroprevalence rates in SSA [10, 11, 12, 13, 14].

Increasing coverage has a limited capacity to compensate for delays in COVID- is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.18.21259164 doi: medRxiv preprint adults to receive an acquisition-blocking vaccine averted more infections than 118 prioritizing older adults or random distribution by age (e.g., 15%±3% versus 119 13%±2% and 7%±2%, respectively, when introduced at day 60, Figure 3 , Age groups for prioritization were as follows: "old first" = beginning with adults age 70 years or older; "young first" = beginning with adults age 15-49 years; "random" = without prioritization (i.e., all ages have equal priority).

By comparison, prioritizing older adults was consistently more effective 127 at averting severe cases or deaths than prioritizing younger adults or random 128 distribution by age. For an acquisition-blocking vaccine, prioritizing older 129 9 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figures 1, 2) .

For the majority of vaccination scenarios, we found that rural priori- 14 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.18.21259164 doi: medRxiv preprint the slow roll-out of vaccine over a 12-month period, particularly during the 215 first 9 months when <50% of the vaccine will have been distributed [17] .

The differences between acquisition-blocking and disease-blocking vac- CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.18.21259164 doi: medRxiv preprint viously exposed urban population encapsulates what we expect is a dilemma 264 that countries may be facing in the near future. In this study we found that 265 vaccinating rural areas may have benefits beyond equity. [28] . In such situations, future outbreaks may continue to resemble new 306 outbreaks, leading to successive almost-memoryless incidence peaks. In ad-307 dition, the vaccine roll-out in SSA has been limited thus far, making our 308 assumption reasonable that future vaccinations will essentially be starting 309 anew. As of June 2021, the Africa CDC reported that less than 2% of mem-310 ber country populations received at least one dose of any vaccine and less 311 than 0.5% have been fully vaccinated [29] . Therefore, variants and low ex-312 isting vaccine-induced immunity suggest our model and other outbreak-type 313 18 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.18.21259164 doi: medRxiv preprint models will continue to have relevance.

Our study had several limitations. As an abstraction of a SSA country Individuals were created at model initialization and assigned (a) an age to 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 2 ).

To derive a mean value for SSA, we used the mean N P I t across countries 413 in SSA for each date since respective first case 7. (1 − N P I t /100) was used 414 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.18.21259164 doi: medRxiv preprint as a contact rate multiplier for work and community settings. The school 415 settings was assumed to be closed (i.e., with N P I t = 100) for 135 days 416 after first reported case then reopened with the same contact rate multiplier 417 as work and community settings. The home setting was assumed to have 418 increased contact rates by 25% (i.e., with N P I t = −25)). After the last day 419 of available N P I t data, work, school, and community settings were assumed 420 to be opened to 75% of pre-COVID levels (i.e., with N P I t = 25) to simulate 421 near-complete reopening in most SSA countries. We used the same multiplier

(1 − N P I t /100) on migration between all spatial nodes in the simulation to 423 account for changes in migration because of NPI policies. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. (Table 1) . 455 Different age prioritization schemes were assumed to be available: oldest Figure 9 ). Likewise, different spatial allocation schemes were assumed vi-459 able: urban first, rural first, or random (equal priority to urban and rural ar-460 eas) (Figure 9 ). Under random spatial prioritization, vaccine was distributed 461 to urban and rural nodes at a rate proportional to population size, e.g., at 1% 462 coverage, both 1% of the urban population and 1% of the rural population 463 would be covered. In the case of both age and spatial prioritization, age was 464 assumed to take precedence before spatial (urban, rural) setting. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.18.21259164 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 21, 2021. ; https://doi.org/10.1101/2021.06.18.21259164 doi: medRxiv preprint

African Ministers of Health On the COVID-19 situation in 609 Africa

communique-of-the-high-level-emergency-virtual-meeting-of-african-ministers

Help us hold governments ac-612 countable in COVID-19 vaccine distribution

Tracking the emergence of 616 new SARS-CoV-2 variants in South Africa

SARS-CoV-2 genomes 620 from Nigeria reveal community transmission, multiple virus lineages 621 and spike protein mutation associated with higher transmission and 622 pathogenicity

Introduction and local transmission of SARS-CoV-626 2 cases in Kenya

CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted

Resurgence of COVID-19 in Manaus, Brazil, de-631 spite high seroprevalence. The Lancet

COVID-19 Vaccination

Blavatnik School of Govern-639 ment

The use of mobile phone data to inform anal-643 ysis of COVID-19 pandemic epidemiology

Safety and Efficacy of the BNT162b2 mRNA Covid-19

Efficacy and Safety of the mRNA-1273 SARS

Implementation and applications of EMOD, an individual-657 based multi-disease modeling platform

About Africa

World Population Prospects -Population Division -United Nations

Se-665 rial interval of SARS-CoV-2 was shortened over time by nonphar-666 maceutical interventions

COVID-19) Dashboard. Geneva: World Health Or-669 ganization

Estimating in-671 fluenza vaccine efficacy from challenge and community-based study 672 data

Parameter ranges for scenarios 482 We evaluated vaccine distribution scenarios over a range of base trans-483 mission intensities represented by R 0 and migration rates. In the scenarios 484 presented, R 0 varied between 2.0 to 2.8. Migration varied from a scenario 485 where simulated agents make 2000 daily trips per million individuals (dtpmi) 486 28 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted June 21, 2021. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 21, 2021. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted June 21, 2021.